Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity ; volume:27 ; number:2 ; year:2020 ; pages:103-114
Portuguese journal of gastroenterology ; 27, Heft 2 (2020), 103-114
- Urheber
-
Martins, Pedro
Verdelho Machado, Mariana
- DOI
-
10.1159/000501405
- URN
-
urn:nbn:de:101:1-2020030423022391140931
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Martins, Pedro
- Verdelho Machado, Mariana
Ähnliche Objekte (12)
Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients
Bacterial cholangitis causing secondary sclerosing cholangitis: A case report
Secondary Sclerosing Cholangitis in critically-ill patients: Risikofaktoren, Diagnostik, Prognose und Therapie
Primary sclerosing cholangitis
Secondary sclerosing cholangitis after chemotherapy with bevacizumab and paclitaxel
COVID-19-associated secondary sclerosing cholangitis with liver transplantation
Secondary Sclerosing Cholangitis in a Critically Ill Patient with Severe SARS-CoV-2 Infection: A Possibly Emergent Entity during the Current Global Pandemic
Hypereosinophilic Syndrome Secondary to Ulcerative Colitis and Primary Sclerosing Cholangitis
Isolated variant of IgG4-sclerosing cholangitis masquerading as hilar cholangiocarcinoma — an enigmatic entity
Primary Sclerosing Cholangitis Complicated with Aphthoid Colitis Difficult to Diagnose from IgG4-Related Sclerosing Cholangitis
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients
Biliary Cast Syndrome and Secondary Sclerosing Cholangitis in Critically Ill Patient after Long-Term Treatment in the Intensive Care Unit
Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients
Bacterial cholangitis causing secondary sclerosing cholangitis: A case report
Secondary Sclerosing Cholangitis in critically-ill patients: Risikofaktoren, Diagnostik, Prognose und Therapie
Primary sclerosing cholangitis
Secondary sclerosing cholangitis after chemotherapy with bevacizumab and paclitaxel
COVID-19-associated secondary sclerosing cholangitis with liver transplantation
Secondary Sclerosing Cholangitis in a Critically Ill Patient with Severe SARS-CoV-2 Infection: A Possibly Emergent Entity during the Current Global Pandemic
Hypereosinophilic Syndrome Secondary to Ulcerative Colitis and Primary Sclerosing Cholangitis
Isolated variant of IgG4-sclerosing cholangitis masquerading as hilar cholangiocarcinoma — an enigmatic entity
Primary Sclerosing Cholangitis Complicated with Aphthoid Colitis Difficult to Diagnose from IgG4-Related Sclerosing Cholangitis
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients
Biliary Cast Syndrome and Secondary Sclerosing Cholangitis in Critically Ill Patient after Long-Term Treatment in the Intensive Care Unit
Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients
Bacterial cholangitis causing secondary sclerosing cholangitis: A case report
Secondary Sclerosing Cholangitis in critically-ill patients: Risikofaktoren, Diagnostik, Prognose und Therapie
Primary sclerosing cholangitis
Secondary sclerosing cholangitis after chemotherapy with bevacizumab and paclitaxel
COVID-19-associated secondary sclerosing cholangitis with liver transplantation
Secondary Sclerosing Cholangitis in a Critically Ill Patient with Severe SARS-CoV-2 Infection: A Possibly Emergent Entity during the Current Global Pandemic
Hypereosinophilic Syndrome Secondary to Ulcerative Colitis and Primary Sclerosing Cholangitis
Isolated variant of IgG4-sclerosing cholangitis masquerading as hilar cholangiocarcinoma — an enigmatic entity
Primary Sclerosing Cholangitis Complicated with Aphthoid Colitis Difficult to Diagnose from IgG4-Related Sclerosing Cholangitis
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients